For THY1 membrane glycoprotein (10-fold upregulated in our study), it was shown that overexpression decreases the activity of PPARγ and blocks adipocyte formation and it could therefore become a therapeutic target in obesity [40]. Here, PPARG is linked to obesity disorder.